JPL Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
JPL Wealth Management's MRNA Position: Q3 2026 in Review
JPL Wealth Management increased its Moderna (MRNA) stake by 1,670% in Q3 2026, buying an estimated $18K and bringing the position to 177 shares worth $34.1K. The position accounts for 0.01% of the portfolio, ranked #257.
JPL Wealth Management first reported a position in MRNA in Q3 2025 and has held it in 4 quarters since. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- JPL Wealth Management held 177 shares of Moderna worth $34.1K as of Q3 2026.
- JPL Wealth Management bought 167 Moderna shares in Q3 2026, an estimated $18K.
- Moderna made up 0.01% of JPL Wealth Management's portfolio in Q3 2026, its #257 holding.
- JPL Wealth Management first reported a position in Moderna in Q3 2025 and has held it in 4 quarters since.
- 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on JPL Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.